Ma Feng, Li Tao, Zhang Huan, Wu GuanJi
Department of Cardiovascular Medicine, Xi'an Central Hospital, Xi'an, China.
J Cardiovasc Pharmacol. 2016 Nov;68(5):327-333. doi: 10.1097/FJC.0000000000000419.
Atherosclerosis (As) is a common disease, which is serious hazard to human health. As the main pathological basis of ischemic cardiac and cerebral vascular disease, including coronary heart disease, cerebrovascular disease, and thromboembolic disease, it is a chronic inflammatory lesion of the arterial vessel wall. So far the pathogenesis of As has not been fully understood. Therefore, it is still lack of effective clinical prevention and treatment of drugs. More and more evidence indicate that miRNA plays an important role in the pathophysiology of many diseases, especially the occurrence and development of cardiovascular diseases. MiRNAs are widely detected in human coronary artery endothelial cells, which might participate in diverse biological functions through targeting different As associated genes. The aim of this study was to investigate the molecular mechanisms underlying miR-30s roles in As. Our study found the high expression of miR-30b and miR-30e in As clinical samples, identified the regulatory relationship of miR-30b and miR-30e to ITGA4 and PLCG1, respectively, and initially explored the effects of miR-30b and miR-30e on cell cycle and apoptosis through targeting ITGA4 and PLCG1. These data may provide a theoretical basis for clarifying the mechanism of miR-30s in As.
动脉粥样硬化(As)是一种常见疾病,对人类健康构成严重危害。作为缺血性心脑血管疾病的主要病理基础,包括冠心病、脑血管疾病和血栓栓塞性疾病,它是动脉血管壁的慢性炎症性病变。迄今为止,As的发病机制尚未完全阐明。因此,临床上仍缺乏有效的防治药物。越来越多的证据表明,微小RNA(miRNA)在许多疾病的病理生理学中发挥着重要作用,尤其是在心血管疾病的发生和发展过程中。miRNA在人冠状动脉内皮细胞中广泛存在,可能通过靶向不同的As相关基因参与多种生物学功能。本研究旨在探讨miR-30s在As中作用的分子机制。我们的研究发现miR-30b和miR-30e在As临床样本中高表达,分别鉴定了miR-30b和miR-30e与整合素α4(ITGA4)和磷脂酶Cγ1(PLCG1)的调控关系,并初步探讨了miR-30b和miR-30e通过靶向ITGA4和PLCG1对细胞周期和凋亡的影响。这些数据可能为阐明miR-30s在As中的作用机制提供理论依据。